Immune complement-system activation platform for cancer and autoimmune disease
| Date | Round | Amount |
|---|---|---|
| May 2024 | Seed Aarhus biotech Commit Biologics raised a €16M seed round led by Bioqube Ventures and Novo Holdings to advance its BiCE complement-engaging platform. | $17.3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.